Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Divis Lab gets green nod for 100 crore modernisation project

      Divis Lab gets green nod for 100 crore modernisation project

      Ruby Khatun Khatun15 Aug 2017 9:51 AM IST
      New Delhi: Divis Laboratories has received environment clearance for the modernisation of its bulk drug unit in Visakhapatnam that will entail a cost...
      Boehringer Ingelheim achieves good growth in the first half of 2017

      Boehringer Ingelheim achieves good growth in the first half of 2017

      Ruby Khatun Khatun15 Aug 2017 9:45 AM IST
      Ingelheim, Germany: Boehringer Ingelheim has delivered positive results for the first half of 2017. Net sales increased by 24 per cent on the same...
      Billionaire Dilip Shanghvi offers mea culpa after Sun Pharma loss: Bloomberg Report

      Billionaire Dilip Shanghvi offers mea culpa after Sun Pharma loss: Bloomberg Report

      Ruby Khatun Khatun14 Aug 2017 12:40 PM IST
      by Ari AltstedterThe billionaire founder of Sun Pharmaceutical Industries Ltd. pledged that the drugmaker would do better after reporting its first...
      Alkem Labs to tap domestic, international markets for growth

      Alkem Labs to tap domestic, international markets for growth

      Ruby Khatun Khatun14 Aug 2017 11:51 AM IST
      New Delhi: Drug firm Alkem Laboratories is looking to tap domestic as well as international markets for growth going forward, the company has said.In...
      FDA advisory committee votes in favor of tofacitinib citrate for the treatment of active psoriatic arthritis

      FDA advisory committee votes in favor of tofacitinib citrate for the treatment of active psoriatic arthritis

      Ruby Khatun Khatun14 Aug 2017 10:15 AM IST
      NEW YORK: Pfizer Inc. announced that the United States Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10 to 1 to...
      Incentives are given to Farmers for Cultivation of Medicinal Plants: Shri Shripad Naik

      Incentives are given to Farmers for Cultivation of Medicinal Plants: Shri Shripad Naik

      Ruby Khatun Khatun14 Aug 2017 9:49 AM IST
      The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through a written reply to a question in Lok Sabha informed that...
      FDA warns of potential contamination in multiple brands of drugs, dietary supplements

      FDA warns of potential contamination in multiple brands of drugs, dietary supplements

      Ruby Khatun Khatun14 Aug 2017 9:30 AM IST
      The U.S. Food and Drug Administration (FDA) is advising consumers and health care professionals not to use any liquid drug or dietary supplement...
      Three healthcare-focused funds keen to pick minority stake in Morpheus IVF

      Three healthcare-focused funds keen to pick minority stake in Morpheus IVF

      Ruby Khatun Khatun14 Aug 2017 9:25 AM IST
      MUMBAI: Morpheus IVF wants to sell a minority stake for which it has attracted the interest of major healthcare-focused funds Quadria Capital, Asian...
      NPPA fixes ceiling prices of 9 scheduled formulations, check out details

      NPPA fixes ceiling prices of 9 scheduled formulations, check out details

      Ruby Khatun Khatun13 Aug 2017 8:46 PM IST
      New Delhi: Through a recent notice Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and the National...
      Over 1000 new chemist shops to provide cheaper medicines in UP

      Over 1000 new chemist shops to provide cheaper medicines in UP

      Ruby Khatun Khatun13 Aug 2017 10:20 AM IST
      Lucknow: In order to provide quality medicines at cheaper prices to those from the economically weaker sections, over 1,000 jan aushadhi kendras would...
      German regulator denies GMP nod to DRLs Bachupally Unit 2

      German regulator denies GMP nod to DRLs Bachupally Unit 2

      Ruby Khatun Khatun13 Aug 2017 10:15 AM IST
      New Delhi: Drug firm Dr Reddy's Laboratories (DRL) said the German regulator has not renewed good manufacturing practice (GMP) compliance certificate...
      53 species of medicinal plants are under threatened categories: AYUSH Minister

      53 species of medicinal plants are under threatened categories: AYUSH Minister

      Ruby Khatun Khatun13 Aug 2017 10:00 AM IST
      The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through written reply to a question in Lok Sabha informed that 53...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok